Wenbin z meghan mc qingsong c tangfeng l kamaleshwar s weimin g Danielle Irby Doctor of pharmacy candidate 2019 Mentor Dr Yogesh Kulkarni Background Information Lung Cancer ID: 911974
Download Presentation The PPT/PDF document "Curcumin and Vitamin E Protect against A..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Curcumin and Vitamin E Protect against Adverse Effects of Benzo[a]pyrene in Lung Epithelial Cells
Wenbin
z,
meghan
mc,
qingsong
c,
tangfeng
l,
kamaleshwar
s,
weimin
g
Danielle Irby
Doctor of pharmacy candidate 2019
Mentor: Dr. Yogesh Kulkarni
Slide2Background Information
Slide3Lung Cancer
Lung cancer is the deadliest cancer among both men and women. About 1 out of 4 cancer-related deaths are from lung cancer. The American Cancer Society projects there to be 222,500 new cases and 155,870 deaths from lung cancer in 2017.
Etiology
Tobacco smoking
Including secondhand smoke
Environmental and workplace exposure
Treatment
varies based on the stage of cancer the patient is in. Options can range surgery to chemotherapy and radiation therapy.
Slide4Benzo[a]pyrene
Benzo[a]pyrene (
BaP
) is a polycyclic aromatic hydrocarbon that acts as one of the major carcinogens in cigarette smoke.
IARC 1
Carcinogen
Metabolized in to Ba-P-7,8-diol-9,10-epoxide (BPDE)
BPDE, the carcinogenic form of
BaP
, can either be metabolized or form adducts with DNA and cause DNA damage
Research reveals
BaP
also induces oxidative stress
Slide5Curcumin
Active compound found in Turmeric
Turmeric (
Curcuma longa
) has long been used for medicinal purposes, such as fighting infection, inflammation reduction and digestive problems. It is cooked in many foods, and known for giving Indian curry its flavor and yellow color.
Powerful antioxidant – scavenger of superoxide O2- and hydrogen peroxide H2O2
Studies have shown curcumin to have
chemopreventive
effects
fat-soluble antioxidant
α
-tocopherol, used in this study, is one of abundant forms of vitamin E and is the most biologically active variant
Vitamin E
Slide6Materials
Slide7Materials
Curcumin (98% pure),
BaP
, α-tocopherol succinate, and DMSO (Sigma Chemical Co.: MO, USA). Stock concentrations of 50 µM for curcumin and VE.
BaP-tetrol
standards were purchased from
MRIGlobal
Chemical Carcinogen Reference Standard Repository (MO, USA)
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) purchased from
Usb Corporation. (CA, USA)DNEasy Blood and Tissue Kits (QIAGEN: MD, USA)
Acetonitrile (ACN) and ammonium
formate
(AF) were purchased from Merck (Darmstadt, Germany).
HCl was from Fischer Scientific (Fair Lawn, NJ)
Slide8Cell Culture
BEAS-2B
Human bronchial epithelial cell line
American Type Culture Collection (ATCC)
Cultured in LHC-9 (Life Technology, MI) complete growth medium supplemented with penicillin and streptomycin.
Incubate at 37°C in 5% CO
2
.
Slide9Purpose
…“to elucidate the role of curcumin and VE (vitamin E) in cellular remediation after acute exposure to
BaP.
”
Slide10Methods and Results
Slide11Methods: MTT Assay
MTT assays measure cell viability through the quantification of formazan production in a sample of cells. Viable cells can reduce MTT to formazan, which is purple in color.
cells/well
Treatments:
BaP
alone (0-80 µM) for 24 and 48h
Curcumin (0-80 µM) or VE individually for 24, 48, and 72h
Co-treatment with
BaP
(5
µM) and VE (0-80 µM) for 24h
Co-treatment with
BaP
(5 µM) and curcumin (0-80 µM) for 24h
MTT solution (5mg/mL) was added and incubated with the cells for 3h.
After solubilizing with DMSO, absorbance was read at 570 nm.
Drug Treatments
Using results from the MTT assay further treatments were done using:
5 µM
BaP
5 µM Curcumin
20 µM VE
Slide16ROS Assay
Reactive oxygen species formation was detected using 2,7-dichlorofluorescein diacetate (DCFDA) (Sigma Chemical Co., MO). This non-fluorescent probe is de-
esterfied
intracellularly to form 2,7-dichlorofluorescein.
Slide17ROS Assay continued
96-well plate
Treated with previously mentioned drug treatments for 24h
Washed with 200 µL PBS
Incubated with 100 µL of 20 µM DCFDA solution for 45 min at 37°C
Measured fluorescence released: excitation 485 nm, emission 535 nm
Slide18Slide19Flow Cytometry
Flow cytometry was used to measure the percentage of cells in the pre-G1, G0/G1, S and G2/M phases of the cell
cyle
.
cells from each treatment group collected
Fixed in 70% ethanol for >24h at 4°C
Stained with Guava Cell Cycle Reagent and run on a Guava
EasyCyte
Flow Cytometer (Millipore Corporation, MA)
events were counted and phase percentages were determined using
GuavaSoft
software (Millipore)
Each sample was run in triplicate
Flow Cytometry continued
Slide21DNA adduct analysis
Adduct presence was measured using high-performance liquid chromatography (HPLC)
of 24h treated cells
Trypsinized
and,
DNEasy
Blood and Tissue kit, were used to extract DNA
DNA quantity estimated using Nano-Drop 1000
Spectrophotmeter
at 260/280 nm
Samples were dissolved in 0.1 N HCL and acid hydrolyzed at 90°C for 3h
BPDE
tetrol
adducts were determined by HPLC
60 µL per sample, injected onto a C18 column
Eluted for 32 min
1 mL/min
Mobile phase: 90:10 (A:B), Solvent A (5% ACN with 10
mM
AF), Solvent B (100% ACN with 10
mM
AF)
Excitation 344 nm, emission 398 nm
DNA adduct analysis cont.
Slide23qRT
-PCR
Used one-step real time PCR kit with SYBR green for amplification of total RNA (50 ng)
Single-step amplifications performed using
iCycler
IQ (Bio-Rad)*
Slide24Slide25Western blot analysis
Technique used to detect and quantify specific proteins in a sample of cells or tissue homogenates. In this study, immunoblotting was performed using phospho-p53 (Ser 15) (p-p53), p53, PARP-1, COMT, SOD-1 and
survivin
.
24h treatment, washed and lysed with RIPA lysis buffer
BCA Assay using Bradford protein assay (Bio-Rad)
12% SDS polyacrylamide gel electrophoresis
Transferred to polyvinylidene fluoride (PVDF) membranes
Blocked with 3% milk, then probed with primary antibody (Santa Cruz Biotechnology) overnight at 4°C (α-tubulin was used as an internal control)
Washed and incubated with secondary antibody (Cell Signaling) for 1h at room temperature
Briefly incubated with chemiluminescence then exposed to X-ray film (Fujifilm Corp., Tokyo)
Slide26Slide27Statistical Analysis of Results
Analysis of variance (ANOVA) for cell viability tests, ROS production and DNA adducts.
Probit
analysis was performed to calculate IC50s.
One-way ANOVA was used to determine the difference in gene and protein expression between groups
Differences at P<0.05 were considered statistically significant
Slide28Discussion and Conclusions
As displayed by the results, 5 µM
BaP
is cytotoxic and can induce DNA damage even at acute exposure (24h)
Curcumin has pleiotropic effects on cell death and survival, while Vitamin E exhibits biphasic qualities
Antioxidants, curcumin and VE, are
cytoprotective
against
BaP
-induced cytotoxicity in BEAS-2B cells by
attenuating ROS production
Reducing the
BaP
-induced increase in activated p53 activation and PARP-1*Reversal of BaP-induced survivin down-regulation (Curcumin)Significant reduction of BPDE-DNA adduct formation
The first study to report the protective effects of VE against DNA damage caused by short-term
BaP
exposure
Curcumin and VE do not reduce
BaP
-induced DNA damage through the regulation of CYP genes involved in
BaP
metabolism
*proposed to be attributed to the reduced oxidative stress and DNA damage in
BaP
-treated cells by Curcumin and VE treatment
Slide29References
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0092992
https://www.ncbi.nlm.nih.gov/books/NBK22268/
https://pubchem.ncbi.nlm.nih.gov/compound/benzo_a_pyrene#section=Wikipedia
http://www.umm.edu/health/medical/altmed/herb/turmeric
http://www.sigmaaldrich.com/catalog/product/sigma/d6883?lang=en®ion=US
https://www.bio.umass.edu/micro/immunology/facs542/facswhat.htm
Slide30Q&A